Orthofix stock.

NEW YORK, NY / ACCESSWIRE / October 19, 2023 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Orthofix Medical Inc. ("Orthofix" or "the Company") (NASDAQ:OFIX). Investors who purchased Orthofix securities are encouraged to obtain additional information and assist the investigation by …OFIX is a medical device company that provides orthopedic and spine solutions to healthcare providers. The stock has a Morningstar rating of 3 stars, a price/earnings ratio of 45.96, and a dividend yield of 0%. See the latest news, financials, valuations, and sustainability of OFIX on Morningstar.What are the best stocks to buy? Learn how you can make that decision for yourself at InvestorPlace. With the help of experienced financial advisors, InvestorPlace can give you the info you need to form an effective investment strategy. So ...Orthofix Medical Inc. announced that Massimo Calafiore has been named incoming President and Chief Executive Officer. Mr. Calafiore is currently Chief Executive Officer of LimaCorporate S.p.A., and his appointment to Orthofix is expected to be effective in early 2024, following the completion of LimaCorporate?s previously announced …Orthofix Medical Inc. (NASDAQ:OFIX) today reported its financial results for the quarter ended September 30, 2023. Net sales were $184.0 million, earnings per share (“EPS”) was $ (0.77), and adjusted EPS was $0.07. “Orthofix has performed well and operated smoothly following the announcement of our management transition.

10 stocks we like better than Orthofix International When o ur award-winning analyst team has a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, ...

SeaSpine shares will cease trading on the Nasdaq Global Select Market at 8:00 p.m. Eastern Standard Time today, and holders of SeaSpine common stock will receive 0.4163 shares of Orthofix common stock for each share of SeaSpine common stock owned. Orthofix, as the corporate parent entity in the combined company structure, will continue to trade ...

Orthofix Medical Inc. Enters into Financing Agreement with Blue Torch Finance LLC. Nov. 08. CI. Earnings Flash (OFIX) ORTHOFIX MEDICAL Reports Q3 Revenue $184M, vs. Street Est of $185.8M. Nov. 08. MT. Orthofix Medical Inc. Revises Earnings Guidance for the Year Ending December 31, 2023. 3 analysts have issued 12-month price targets for Orthofix Medical's shares. Their OFIX share price targets range from $12.00 to $16.00. On average, they predict the company's share price to reach $14.00 in the next twelve months. This suggests a possible upside of 22.0% from the stock's current price.Orthofix will report its full financial results for 2021 and provide its financial outlook for 2022 during its earnings announcement planned for February 25, 2022. About Orthofix Orthofix Medical Inc. is a global medical device company with a spine and orthopedics focus.Nov 29, 2023 · Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Orthofix To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Orthofix stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983 ... Orthofix Medical Inc. (NASDAQ: OFIX), a leading global spine and orthopedics company, today announced that Catherine Burzik, Chair of the Orthofix Boa

Orthofix’s then-CEO Robert Vaters, who was not charged with wrongdoing, has reimbursed the company $72,886 for cash bonuses and certain stock awards he received during the period when the company committed accounting violations. Therefore, it wasn’t necessary for the SEC to pursue a Sarbanes-Oxley Section 304(a) clawback …

If you purchased or acquired securities in Orthofix stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

If you purchased or acquired securities in Orthofix stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).SeaSpine shares will cease trading on the Nasdaq Global Select Market at 8:00 p.m. Eastern Standard Time today, and holders of SeaSpine common stock will receive 0.4163 shares of Orthofix common stock for each share of SeaSpine common stock owned. Orthofix, as the corporate parent entity in the combined company structure, will continue to trade ...All these institutional investors and hedge funds hold approximately 88.71% of Orthofix Medical’s stock currently. This level of ownership suggests confidence among major players within the industry regarding the potential growth and profitability of Orthofix Medical. In terms of financial performance on August 2nd, OFIX opened at $19.82 per ...Jan 4, 2023 · SeaSpine shares will cease trading on the Nasdaq Global Select Market at 8:00 p.m. Eastern Standard Time today, and holders of SeaSpine common stock will receive 0.4163 shares of Orthofix common ... Orthofix Medical Stock Performance OFIX stock opened at $11.12 on Monday. The company has a quick ratio of 1.13, a current ratio of 2.58 and a debt-to …When picking the best stocks under $10 to buy, it's important to identify fundamentally strong and non-speculative stocks. These are fundamentally strong and non-speculative stocks that are under $10 Since the meme stock euphoria in 2020, i...

SeaSpine shares will cease trading on the Nasdaq Global Select Market at 8:00 p.m. Eastern Standard Time today, and holders of SeaSpine common stock will receive 0.4163 shares of Orthofix common ...Orthofix Medical had revenue of $668.46M in the twelve months ending September 30, 2023, with 44.20% growth year-over-year. Revenue in the quarter ending September 30, 2023 was $184.01M with 61.41% year-over-year growth. In the year 2022, Orthofix Medical had annual revenue of $460.71M, a decrease of -0.81%.Orthofix Medical Inc. is a global medical device company with a spine and orthopedics focus. The Company operates through two segments: Global Spine and Global Orthopedics. The Global Spine segment consists of three product categories: Bone Growth Therapies, Spinal Implants, and Biologics.Orthofix Medical Inc Registered Shs's market capitalization is $395.96 M by 36.76 M shares outstanding. Is Orthofix Medical stock a Buy, Sell or Hold? Orthofix …Orthofix Medical Stock Up 3.4 %. Shares of NASDAQ:OFIX opened at $11.19 on Tuesday. Orthofix Medical has a 1 year low of $9.57 and a 1 year high of $23.19. The company has a market cap of $411.31 million, a PE ratio of -2.87 and a beta of 1.05. The company has a debt-to-equity ratio of 0.14, a current ratio of 2.58 and a quick ratio of 1.13.

NEW YORK, Nov. 25, 2023 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Orthofix Medical Inc. ("Orthofix" or the "Company") (NASDAQ: OFIX). Faruqi & Faruqi is a leading minority and Woman-owned national securities law firm with offices in New York, Pennsylvania, California ...Presentation Operator MessageOperator Hello, and a warm welcome to Orthofix Medical's Q2 2022 Earnings Call. My name is Melissa, and I'll be your operator today. ... Stock Orthofix Medical Inc. - Nasdaq . News Orthofix Medical Inc. Transcript : Orthofix Medical Inc., Q2 2022 Earnings Call, Aug 05, 2022. CATEGORIES. Indexes ...

Summary. Orthofix Medical Inc.'s merger with SeaSpine has not significantly impacted investor sentiment or market expectations. Despite reasonable Q1 financial results, the lack of forecasted ...On this news, Orthofix's stock price fell $5.62 per share, or 30.17%, to close at $13.01 per share on September 12, 2023. The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation.há 6 dias ... News of the firings sent shares of Orthofix tumbling 30% on Sept. 12. The stock has continued its downturn, shedding another 13.7% since ...Under the terms of the agreement, which was unanimously approved by the Boards of Directors of both companies, SeaSpine shareholders will receive 0.4163 shares of Orthofix common stock for each ...Orthofix Shareholder Notice If you purchased or acquired securities in Orthofix stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).Orthofix Medical Inc (NASDAQ: OFIX) and SeaSpine Holdings Corp (NASDAQ: SPNE) have agreed to combine in an all-stock merger of equals. Each SeaSpine share will be exchanged for 0.4163 Orthofix shares.If you purchased or acquired securities in Orthofix stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).Nov 29, 2023 · Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the publication of the five-year results from the U.S. clinical study comparing the M6-C ™ artificial cervical disc with anterior cervical discectomy and fusion (ACDF). On November 8, Orthofix Medical is presenting Q3 earnings. Wall Street analysts expect Orthofix Medical will report losses per share of $0.210. Track Orthofix Medical stock price in real-time on ...

The average price point forecasted by analysts for Orthofix Medical Inc (OFIX) is $20.50, which is $9.87 above the current market price. The public float for OFIX is 35.34M, and currently, short sellers hold a 4.26% ratio of that floaft. The average trading volume of OFIX on November 10, 2023 was 630.17K shares. OFIX) stock’s […]

Story continues LEWISVILLE, Texas, November 08, 2023--Orthofix Medical Inc. (NASDAQ:OFIX) today reported its financial results for the quarter ended September …

Orthofix Intl NV stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. ... Stocks whose Next Earnings Date falls within the next 7 days are highlighted in red. Annual Dividend & Yield: The annual dividend rate and yield, calculated from the latest dividend. The dividend rate is the ...Orthopedics. Orthofix offers innovative and minimally invasive extremity solutions to help surgeons improve their patient’s quality of life. Designed to address the lifelong bone and joint health needs of patients of all ages, our orthopedics products help patients achieve a more active and mobile lifestyle when compared to other surgical solutions. Orthofix (OFIX) delivered earnings and revenue surprises of -155.56% and 1.64%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?Orthofix (OFIX) delivered earnings and revenue surprises of 102.99% and 1.75%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?12 de set. de 2023 ... Orthofix's shares fell 17.1 percent Tuesday morning after the company announced that three C-suite leaders were terminated after an ...Orthofix Shareholder Notice If you purchased or acquired securities in Orthofix stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).13 hours ago · Orthofix Medical Inc. (NASDAQ:OFIX) shares fell 5.4% to $10.52 in pre-market trading. Sealed Air will replace Orthofix Medical in the S&P SmallCap 600, effective prior to the open of trading on ... Shares of Orthofix Medical (NASDAQ: OFIX) were down more than 26% as of 2:15 p.m. ET on Tuesday after the healthcare company announced it had fired CEO Keith Valentine, CFO John Bostjancic, and ...5 de jan. de 2023 ... SeaSpine shares also ceased trading on the Nasdaq global market this morning. Holders of SeaSpine common stock will receive 0.4163 shares of ...Mar 7, 2023 · Orthofix Medical Inc. (NASDAQ:NASDAQ:OFIX) Q4 2022 Earnings Conference Call March 6, 2023 4:30 PM ETCompany ParticipantsAlexa Huerta - Senior Director,... Orthofix Medical Stock Performance. Shares of Orthofix Medical stock opened at $11.12 on Monday. The firm has a market cap of $408.77 million, a P/E ratio of -2.85 and a beta of 1.02. The company ...

OFIX is a medical device company that provides orthopedic and spine solutions to healthcare providers. The stock has a Morningstar rating of 3 stars, a price/earnings ratio of 45.96, and a dividend yield of 0%. See the latest news, financials, valuations, and sustainability of OFIX on Morningstar.Nov 1, 2023 · Orthofix appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release ... Orthofix Medical Inc. is a global medical device company with a spine and orthopedics focus. The Company operates through two segments: Global Spine and Global Orthopedics. The Global Spine segment consists of three product categories: Bone Growth Therapies, Spinal Implants, and Biologics.Instagram:https://instagram. ria registered investment advisorforex trading online brokersstock dividend calendarambetter insurance rating Orthofix Medical Inc. OFIX (U.S.: Nasdaq) Overview News Orthofix Medical Inc. No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) N/A EPS …Exhibit 10.9 . ORTHOFIX MEDICAL INC. SECOND AMENDED AND RESTATED. STOCK PURCHASE PLAN, AS AMENDED . 1.Purpose. The purpose of the Plan is to encourage eligible employees and directors to become owners of common stock of Orthofix Medical Inc., thereby giving them a greater interest in the growth and success of its business. vsp standard planxbil etf dividend Orthofix Medical Inc. is a global medical device company with a spine and orthopedics focus. The Company operates through two segments: Global Spine and Global Orthopedics. The Global Spine segment consists of three product categories: Bone Growth Therapies, Spinal Implants, and Biologics. ilmn news Stock Information · Stock Quote · Stock Chart · Historical Stock Quote · Analyst Coverage · Financials · Quarterly Results · Annual Reports · SEC Filings ...If you purchased or acquired securities in Orthofix stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).